- Accesswire•7 days ago
NEW YORK, NY / ACCESSWIRE / March 16, 2017 / The inside investors of Exelixis and MannKind corporations have sold some of their company stock today. One Director cashed in on a $20 a share price increase, ...
- Motley Fool•8 days ago
A new cancer drug that's growing market share rapidly has been catapulting shares of this biotech higher.
- Motley Fool•9 days ago
Two little numbers and one big number are key for Exelixis' future.
EXEL : Summary for Exelixis, Inc. - Yahoo Finance
Exelixis, Inc. (EXEL)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||16.03 x 200|
|Ask||21.94 x 500|
|Day's Range||20.02 - 20.85|
|52 Week Range||3.64 - 23.49|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-73.14|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|